comparemela.com

Latest Breaking News On - Valdecilla - Page 5 : comparemela.com

Improving dialogue between healthcare professionals and patients in bladder cancer

In this interview, Dr. Ignacio Duran and Alex Filicevas focus on improving dialogue between healthcare professionals and patients, outlining ways in which we can encourage open discussion to improve the overall patient experience.

United statesUnited kingdomJanssen pharmaceuticalsaugAlex smithUniversitario marquAlex filicevasSpanish society of medical oncologyAmerican society of clinical oncologyScan internationalIntj environ res public healthWorld bladder cancer patient coalitionCancer research united kingdomCompanies of johnsonJanssen pharmaceuticalsEuropean society for medical oncologyStanford health care

In Utero COVID Exposure Tied to Developmental Differences

The offspring of women who get COVID-19 during pregnancy may face an increased risk for neurodevelopmental differences, although more data are required to confirm the association, investigators say.

Comunidad autonoma de catalunaRosa ayesa arriolaSalud carlosCastro quintasLivio provenziUniversitario marquEnvironmental sciencesUniversity of barcelonaValdecilla research instituteEuropean psychiatric associationMore researchUniversity of paviaDepartment of evolutionary biologySpanish ministry of economyHospital universitario marquNetwork centre

Photos: Trick-of-the-Eye Street Art That Makes You Move in Close, Then Take a Step Back

Spanish painter Silvestre Santiago, better known as Pejac, creates incredible street art. Playing with perspective, he produces trick-of-the-eye .

New yorkUnited statesCity ofUnited kingdomSilvestre santiagoTimes photoSocial distancingEpoch timesStreet artThe epoch times

European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer | Antibodies

European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer

United statesKenji yasukawaAhsan arozullahEnfortumab vedotinUniversitario marquEuropean commission approvesAmerican society of clinical oncologyEuropean commissionAstellas pharma us incSeagen incI astellas pharma incAstellas pharma incEuropean union eu member statesEuropean unionEuropean medicines agencyLocally advanced

European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer

/PRNewswire/ Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that the.

United statesKenji yasukawaAhsan arozullahEnfortumab vedotinUniversitario marquAmerican society of clinical oncologyAstellas pharma us incEuropean commissionSeagen incExchange commissionAstellas pharma incEuropean union eu member statesEuropean unionEuropean medicines agencyPrnewswire astellas pharma incVice president

vimarsana © 2020. All Rights Reserved.